Original Research

Published on 30 Sep 2022

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma

in Thoracic Oncology

Xueqian Shang
Kang Qi
Xiangzheng Liu
Qinghao Liu
Xining Zhang
Dongliang Wang
Weiming Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.854999

2,886 views
1 citation

Original Research

Published on 29 Sep 2022

Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report

in Thoracic Oncology

Qianqian Xu
Guming Zou
Li Zhuo
Hongmei Gao
Wenge Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1002155

2,450 views
6 citations

Original Research

Published on 29 Sep 2022

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer

in Thoracic Oncology

Zheng Li
Nan Liang
Na Wang
Yan Jia
Cui Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1023776

1,706 views
4 citations

Original Research

Published on 29 Sep 2022

Genomic landscape of lung cancer in the young

in Thoracic Oncology

Rossana Ruiz
Marco Galvez-Nino
Katia Roque
Jaime Montes
Maria Nuñez
Luis Raez
Sergio Sánchez-Gambetta
Sandra Jaúregui
Sandra Viale
Edward S. Smith

Frontiers in Oncology

doi 10.3389/fonc.2022.910117

3,978 views
1 citation

Original Research

Published on 29 Sep 2022

Exploration of the optimal number of regional lymph nodes removed for resected N0 NSCLC patients: A population-based study

in Thoracic Oncology

Anjie Yao
Zixuan Liu
Hanyu Rao
Yilun Shen
Changhui Wang
Shuanshuan Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.1011091

1,438 views
2 citations

Original Research

Published on 28 Sep 2022

Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer

in Thoracic Oncology

Yanli Li
Yanhan Dong
Shupeng Zhao
Jinning Gao
Xiaodan Hao
Zibo Wang
Meng Li
Mengyuan Wang
Yiming Liu
Xiaoling Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.850363

2,391 views
13 citations

Original Research

Published on 28 Sep 2022

m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma

in Thoracic Oncology

Hansheng Wu
Haijie Xu
Shujie Huang
Yong Tang
Jiming Tang
Haiyu Zhou
Liang Xie
Guibin Qiao

Frontiers in Oncology

doi 10.3389/fonc.2022.989817

2,797 views
6 citations

Review

Published on 27 Sep 2022

Advances in the application of proteomics in lung cancer

in Thoracic Oncology

Bai Ling
Zhengyu Zhang
Ze Xiang
Yiqi Cai
Xinyue Zhang
Jian Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.993781

5,375 views
8 citations

Review

Published on 27 Sep 2022

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment

in Thoracic Oncology

Reem Altaf
Sarmad Sheraz Jadoon
Syed Aun Muhammad
Umair Ilyas
Yongtao Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.1014156

3,101 views
8 citations

Original Research

Published on 27 Sep 2022

The association between double-lumen tube versus bronchial blocker and postoperative pulmonary complications in patients after lung cancer surgery

in Thoracic Oncology

Wei Liu
Fan Jin
He-Mei Wang
Fang-Fang Yong
Zhen Wu
Hui-Qun Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.1011849

1,958 views
5 citations

Brief Research Report

Published on 27 Sep 2022

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer

in Thoracic Oncology

Aiping Ma
Guangdong Wang
Yan Du
Weixi Guo
Jiaxi Guo
Yi Hu
Dongyu Bai
Huiping Huang
Lianjin Zhuang
Jinhan Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.902955

3,207 views
8 citations

Original Research

Published on 23 Sep 2022

Prediction of postoperative cardiopulmonary complications after lung resection in a Chinese population: A machine learning-based study

in Thoracic Oncology

Guanghua Huang
Lei Liu
Luyi Wang
Shanqing Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1003722

1,697 views
1 citation

Brief Research Report

Published on 23 Sep 2022

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy

in Thoracic Oncology

Fabian J. Bolte
Sloane McTavish
Nathan Wakefield
Lindsey Shantzer
Caroline Hubbard
Arun Krishnaraj
Wendy Novicoff
Ryan D. Gentzler
Richard D. Hall

Frontiers in Oncology

doi 10.3389/fonc.2022.986236

2,831 views
13 citations

Case Report

Published on 23 Sep 2022

A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review

in Thoracic Oncology

Xiaohu Xu
Dong Chen
Xiao Wu
Qi Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.988625

2,393 views
6 citations

Mini Review

Published on 21 Sep 2022

Minimal residual disease in EGFR-mutant non-small-cell lung cancer

in Thoracic Oncology

Nathan T. Bain
Yang Wang
Surein Arulananda

Frontiers in Oncology

doi 10.3389/fonc.2022.1002714

3,337 views
2 citations

Case Report

Published on 20 Sep 2022

Malignant granular cell tumor in the thoracic wall: A case report

in Thoracic Oncology

Shengnan Gao
Bin Xing
Sun Lichao
Jie Luo
Jiao Tang
Ye Wang
Xiaoyan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.895924

2,561 views
1 citation

Navigation group

Articles

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma

Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer

Genomic landscape of lung cancer in the young

Exploration of the optimal number of regional lymph nodes removed for resected N0 NSCLC patients: A population-based study

Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer

m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma

Advances in the application of proteomics in lung cancer

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment

The association between double-lumen tube versus bronchial blocker and postoperative pulmonary complications in patients after lung cancer surgery

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer

Prediction of postoperative cardiopulmonary complications after lung resection in a Chinese population: A machine learning-based study

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy

A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review

Minimal residual disease in EGFR-mutant non-small-cell lung cancer

Malignant granular cell tumor in the thoracic wall: A case report